Cystinosis

Cystinosis is caused by changes in the CTNS gene that lead to a buildup of cystine inside cells.
A child must inherit two changed copies, one from each parent, to develop cystinosis.
Non-genetic factors do not cause cystinosis, but early diagnosis, regular treatment, and staying well hydrated can help slow complications.
Risk factors for cystinosis include having carrier parents, a family history, or parents who are related by blood.
Doctors distinguish between risk factors you can change and those you can’t.

Genetic risk factors

Most cases of cystinosis stem from inherited changes in the CTNS gene and follow a recessive pattern. These genetic causes of cystinosis usually mean a child receives one nonworking copy from each parent, who typically have no symptoms. In some cases, genetic testing can give a clearer picture of your personal risk.

• CTNS gene changes: Harmful changes in the CTNS gene disrupt a protein that moves cystine out of the cell’s recycling compartments. Cystine then builds up and can damage kidneys, eyes, and other organs.

• Recessive inheritance: A child must inherit two nonworking CTNS copies—one from each parent—to develop cystinosis. Parents with one changed copy are usually healthy carriers.

• Carrier couple risks: When both parents are carriers, each pregnancy has a 25% chance of cystinosis, a 50% chance of a carrier child, and a 25% chance of neither. These chances are the same for boys and girls.

• Common large deletion: A specific large CTNS deletion accounts for many cases in people of Northern European ancestry. Testing panels often include this deletion when evaluating suspected cystinosis.

• Population patterns: Carrier rates can be higher in certain regions or communities because one ancestral change became common over time. Knowing your ancestry can help target which CTNS variants to check first.

• Related parents: Parents who are blood relatives are more likely to carry the same rare CTNS change. This raises the chance of an affected child.

• Variant severity: Changes that completely shut down CTNS function tend to cause the early, kidney‑focused form, while milder changes may lead to later‑onset or eye‑only disease. This pattern helps explain why the condition can look different across families.

• Children of affected: If a person with cystinosis has a partner who is not a carrier, all children will be carriers but not affected. If the partner is a carrier, each child has a 50% chance to have cystinosis.

• Family history: Having an affected sibling means you may be a carrier even if you feel well. An unaffected sibling has a 2-in-3 chance of being a carrier.

• Genetic testing: Testing the CTNS gene can confirm cystinosis and identify the exact changes. Carrier and family testing can clarify personal and reproductive risks.

Transmission

Cystinosis is a genetic condition and is not contagious—you can’t catch it from someone else through touch, sneezing, or sharing items. It follows an autosomal recessive pattern: a child is affected when they inherit two altered copies of the same gene, one from each parent, who are usually healthy carriers. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of cystinosis, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance the child will inherit neither variant. New, spontaneous changes in the gene are uncommon; most cases come from carrier parents, which is the core of how cystinosis is inherited.

When to test your genes

Consider genetic testing if you have a family history of cystinosis, a child with unexplained Fanconi syndrome (excessive urination, thirst, rickets), or early kidney problems without a clear cause. Carrier testing is helpful for partners planning a pregnancy, especially in higher‑risk families. Early diagnosis enables prompt cysteamine therapy and kidney-sparing care.

Looking at the long-term picture can be helpful. For many living with cystinosis, early symptoms of cystinosis in infancy or early childhood—poor growth, frequent urination, salt craving, or fatigue—are often the first clues, and starting treatment early can slow damage to the kidneys and other organs. With the right support, the future can include school, work, and family life, though routines may include medications several times a day, regular blood tests, and eye drops to protect vision.

Prognosis refers to how a condition tends to change or stabilize over time. Without treatment, cystinosis can lead to kidney failure in childhood or adolescence, but modern therapy has significantly improved survival and delayed the need for dialysis or transplant for many people. Even after a kidney transplant, cystinosis can still affect other areas—eyes, thyroid, muscles, bones, and sometimes blood sugar—so ongoing care remains important. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.

Everyone’s journey looks a little different. Some people maintain kidney function for decades with consistent cysteamine therapy and monitoring, while others need transplant earlier despite best efforts. Most deaths now relate to complications in multiple organs rather than the kidneys alone, and they are far less common than in past decades; life expectancy continues to improve as treatments and follow-up care advance. Talk with your doctor about what your personal outlook might look like, including how your age at diagnosis, treatment plan, and response to medication influence the years ahead.

Cystinosis treatment focuses on lowering cystine buildup, protecting organs, and managing day‑to‑day symptoms. The main medicine is cysteamine (oral capsules or solution), which helps move cystine out of cells and can slow kidney damage when started early; eye drops with cysteamine ease light sensitivity and help prevent crystal buildup in the cornea. Doctors also treat features of cystinosis such as dehydration, salt loss, poor growth, and bone changes with fluids, electrolytes, vitamin D, phosphate, and nutrition support, and some people eventually need kidney transplant—after transplant, cysteamine is still continued to protect other organs. Treatment plans often combine several approaches, and a doctor may adjust your dose to balance benefits and side effects. Keep track of how you feel, and share this with your care team so timing, forms (immediate‑ vs extended‑release), and supportive therapies can be fine‑tuned over time.

In cystinosis, genetics drive the condition: it develops when a child inherits two nonworking copies of a gene called CTNS, one from each parent. This pattern is called autosomal recessive inheritance, and parents typically feel well because they carry only one changed copy. A “carrier” means you hold the gene change but may not show symptoms. When both parents are carriers, each pregnancy has a 25% chance (1 in 4) for cystinosis, a 50% chance (1 in 2) for a child who is a carrier, and a 25% chance for a child with no gene change. Genetic testing can identify CTNS changes, including a common large deletion in some populations, and helps clarify risks for siblings and future pregnancies. Even within the same family, the age symptoms start and how severe they become can vary. For families asking how cystinosis is passed down, talking through your family history and considering genetic counseling can support planning and early care.

Living with Cystinosis alongside other health issues can change how symptoms feel day to day—fatigue, thirst, and muscle aches may be more intense when thyroid disease or diabetes is also present. Doctors call it a “comorbidity” when two conditions occur together. Chronic kidney disease commonly develops in Cystinosis and can bring high blood pressure, anemia, and bone–mineral problems; when bone thinning or rickets are also in the picture, bone pain and fracture risk can rise further. After a kidney transplant, the immune‐suppressing medicines needed to protect the graft can increase the chance of infections and may raise blood pressure, cholesterol, and blood sugar, which can compound Cystinosis‑related muscle weakness and fatigue. Eye surface conditions like dry eye or allergies can worsen the light sensitivity and irritation caused by corneal cystine crystals. Interactions can look very different from person to person, so coordinated care across nephrology, endocrinology, and eye care helps tailor treatment when Cystinosis occurs with other diseases.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.